TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer.

Ángel Guerrero-Zotano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.